2023
Exports
$38.4kWorld Rnk 146 / 208
Flag Rnk 532 / 848
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$19.9MWorld Rnk 137 / 222
Flag Rnk 106 / 1119
2023
ECONOMIC COMPLEXITY of Albania
-0.33Rnk 77 / 132

About

Exports In 2023, Albania exported $38.4k in Vaccines, blood, antisera, toxins and cultures, making it the 146th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 532nd most exported product in Albania. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Albania are: Italy ($24.4k), France ($3.97k), Senegal ($3.49k), Netherlands ($2.14k), and Poland ($1.7k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Albania between 2022 and 2023 were Senegal ($3.49k), France ($2.6k), and Netherlands ($2.01k).

Imports In 2023, Albania imported $19.9M in Vaccines, blood, antisera, toxins and cultures, becoming the 137th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most imported product in Albania. Albania imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($4M), Hungary ($2.49M), Austria ($2.26M), Italy ($1.45M), and Netherlands ($1.37M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Albania between 2022 and 2023 were Hungary ($2.27M), Netherlands ($1.03M), and Italy ($958k).

Latest Trends

Dec 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$38.4k
IMPORTS (2023)$19.9M
NET TRADE (2023)-$19.8M

In 2023, Albania exported $38.4k in Vaccines, blood, antisera, toxins and cultures. The main destinations of Albania exports on Vaccines, blood, antisera, toxins and cultures were Italy ($24.4k), France ($3.97k), Senegal ($3.49k), Netherlands ($2.14k), and Poland ($1.7k).

In 2023, Albania imported $19.9M in Vaccines, blood, antisera, toxins and cultures, mainly from Germany ($4M), Hungary ($2.49M), Austria ($2.26M), Italy ($1.45M), and Netherlands ($1.37M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Albania WERE (2022 - 2023):
Senegal$3.49k (1%)
France$2.6k (189%)
Netherlands$2.01k (1.6k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Albania WERE (2022 - 2023):
Italy-$48.2k (-66.4%)
Germany-$2.67k (-68.7%)
Belgium-$1.36k (-92.8%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Albania's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Albania's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALItaly+ $125k
TOP IMPORT POTENTIALGermany+ $5.11M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Italy. With an export gap of $125k.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $5.11M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with